These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1854763)
1. Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantation. Butman SM; Wild JC; Nolan PE; Fagan TC; Finley PR; Hicks MJ; Mackie MJ; Copeland JG J Heart Lung Transplant; 1991; 10(3):351-8. PubMed ID: 1854763 [TBL] [Abstract][Full Text] [Related]
2. Coadministration of ketoconazole and cyclosporine for kidney transplant recipients: long-term follow-up and study of metabolic consequences. Sobh MA; Hamdy AF; El Agroudy AE; El Sayed K; El-Diasty T; Bakr MA; Ghoneim MA Am J Kidney Dis; 2001 Mar; 37(3):510-7. PubMed ID: 11228175 [TBL] [Abstract][Full Text] [Related]
6. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results. Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555 [TBL] [Abstract][Full Text] [Related]
7. Ketoconazole to reduce the need for cyclosporine after cardiac transplantation. Keogh A; Spratt P; McCosker C; Macdonald P; Mundy J; Kaan A N Engl J Med; 1995 Sep; 333(10):628-33. PubMed ID: 7637723 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine. Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine. Vanhaecke J; Van Cleemput J; Van Lierde J; Daenen W; De Geest H Transplantation; 1994 Jul; 58(1):42-5. PubMed ID: 8036706 [TBL] [Abstract][Full Text] [Related]
10. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929 [TBL] [Abstract][Full Text] [Related]
11. Co-administration of ketoconazole to tacrolimus-treated kidney transplant recipients: a prospective randomized study. el-Dahshan KF; Bakr MA; Donia AF; Badr Ael-S; Sobh MA Nephrol Dial Transplant; 2004 Jun; 19(6):1613-7. PubMed ID: 15034161 [TBL] [Abstract][Full Text] [Related]
12. Use of cyclosporine and ketoconazole without nephrotoxicity in two heart transplant recipients. Schroeder TJ; Melvin DB; Clardy CW; Wadhwa NK; Myre SA; Reising JM; Wolf RK; Collins JA; Pesce AJ; First MR J Heart Transplant; 1987; 6(2):84-9. PubMed ID: 3305834 [TBL] [Abstract][Full Text] [Related]
13. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat). Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731 [TBL] [Abstract][Full Text] [Related]
14. Cyclosporine-ketoconazole interaction. Long-term follow-up and preliminary results of a randomized trial. First MR; Schroeder TJ; Michael A; Hariharan S; Weiskittel P; Alexander JW Transplantation; 1993 May; 55(5):1000-4. PubMed ID: 8497871 [TBL] [Abstract][Full Text] [Related]
15. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study. Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040 [TBL] [Abstract][Full Text] [Related]
16. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. Herzberg GZ; Rossi AF; Courtney M; Gelb BD J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760 [TBL] [Abstract][Full Text] [Related]
17. Anti-CD3 monoclonal antibody induction therapy. Immunological equivalency with triple-drug therapy in heart transplantation. Barr ML; Sanchez JA; Seche LA; Schulman LL; Smith CR; Rose EA Circulation; 1990 Nov; 82(5 Suppl):IV291-4. PubMed ID: 2121387 [TBL] [Abstract][Full Text] [Related]
18. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation. Olivari MT; Jessen ME; Baldwin BJ; Horn VP; Yancy CW; Ring WS; Rosenblatt RL J Heart Lung Transplant; 1995; 14(1 Pt 1):127-35. PubMed ID: 7727461 [TBL] [Abstract][Full Text] [Related]
19. Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy. Olivari MT; Antolick A; Ring WS J Heart Transplant; 1989; 8(1):34-9. PubMed ID: 2647929 [TBL] [Abstract][Full Text] [Related]
20. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study. Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]